Michelle is the Chief Investment Officer at MedAccess, where she manages its guarantee portfolio, through the development of short-term and long-term investment plans, investment analysis, and the monitoring and management of investments.
Before joining MedAccess, Michelle was a Managing Director at Bank of America Merrill Lynch in the Corporate Finance & Restructuring team. She initially joined Merrill Lynch in 2001, and worked in the Leveraged Finance teams in London and Hong Kong. From 2006 to 2009, she worked as a buyside investor, which encompassed structuring both cash and synthetic credit investments, before rejoining Merrill Lynch in 2010. Her career first began in the field of medicine, working in the National Health Service after graduating from the University of Oxford with a BA in Physiological Sciences and a BM, BCh.